ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1259

Factors Influencing Patient’s Participation in Rheumatology Research Studies: Experience from a Single Academic Centre

Mumtaz Khan1, John A. Reynolds2, Kanta Kumar3, Sarah Peters3, Christianah Yemidale4, Ian N. Bruce5 and Benjamin Parker6, 1Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 3University of Manchester, Manchester, United Kingdom, 4Manchester University Hospital, Manchester, United Kingdom, 5NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, UK, Manchester, United Kingdom, 6Centre for Musculoskeletal Research, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Participation, Research and Rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Healthcare Disparities in Rheumatology - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There is a drive to offer all patients the opportunity to participate in clinical research. We aimed to investigate the eligibility, screening and participation of rheumatology patients in clinical research studies in a single academic rheumatology department to identify targets for improving patient engagement with research

Methods: Methods: This study was conducted in two phases. Phase 1 was a retrospective analysis of study screening logs over 12 months. In phase 2; the outpatient population was surveyed using a questionnaire to identify the motivators and barriers to research participation. Comparisons were made using chi-squared tests and logistic regression models where appropriate.

Results: In phase 1 of the study we identified 1025 patients who were eligible for screening (median [IQR] age 47 [18-85] years; 87% female); 566 (55%) had been screened for any study. Of these, 217/566 (38%) were subsequently enrolled. Enrollment varied by ethnicity. Reasons for screen failure included study ineligibility (54%) and patient factors (29%). There was significant variation in these reasons by ethnicity (P=0.047), however this was not clearly due to patient factor (P = 0.091). Females were more likely to be ineligible (OR [95% CI] 1.78 [1.08, 2.95]) and increased age was associated with declining research participation (OR 0.98 [0.95, 0.998]). In phase 2, 152 participants including 117 (77%) women, responded to our survey (overall response rate 25% [Caucasians 45%, Non-Caucasians 7%]). Their median [IQR] age was 50 [17-84] yrs and our sample included 111 (73%) Caucasians and 41(27%) non-Caucasian ethnicity. Overall, 50 (33%) had ever been invited to research, of whom 71% participated. The key motivational factors were to contribute to scientific knowledge (94%), to help other patients (89%) and personal health benefits (47%). The major factors for non-participation were study ineligibility (47%), stopping/changing current medication (33%), inadequate information about the study (27%) and inconvenience (27%). Overall, 87/152 (57%) were happy to participate in future studies .The main influencing factors were potential help to others (98%),contributing to scientific knowledge(96%),quality of information given about the study (79%) and understanding of what study involved (76%). Non-Caucasians were less likely to participate (p=0.052); however, main spoken language (p=0.102) and employment status (P=0.395) had no influence on deciding whether to take part in research. We also found that Caucasians were significantly more likely to be approached to research (P=0.004) and previous research experience had a positive impact to participate in future research (P=0.001).

Conclusion: Our study identified a number of barriers to research participation. Almost half of patients were never even considered or screened for research eligibility, and many failed screening. This may reflect study case mix/design; however there was also variability in participation according to ethnicity. Strategies to facilitate a universal research offer and support study involvement will need to account for ethnic variation in patient characteristics and beliefs about research.


Disclosure: M. Khan, None; J. A. Reynolds, None; K. Kumar, None; S. Peters, None; C. Yemidale, None; I. N. Bruce, None; B. Parker, None.

To cite this abstract in AMA style:

Khan M, Reynolds JA, Kumar K, Peters S, Yemidale C, Bruce IN, Parker B. Factors Influencing Patient’s Participation in Rheumatology Research Studies: Experience from a Single Academic Centre [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/factors-influencing-patients-participation-in-rheumatology-research-studies-experience-from-a-single-academic-centre/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-influencing-patients-participation-in-rheumatology-research-studies-experience-from-a-single-academic-centre/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology